Smart Inhalers Market Scope And Analysis

  • Report Code : TIPRE00004568
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Smart Inhalers Market Analysis, Trends, and Scope 2024 to 2031

Buy Now

Smart Inhalers Market Report Smart Inhalers Market Size and Share Smart Inhalers Market Scope and Analysis

Smart Inhalers Market Report Scope

Report Attribute Details
Market size in 2023 US$ 2.95 Billion
Market Size by 2031 US$ 23.98 Billion
Global CAGR (2023 - 2031) 29.9%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Nebulizers and Inhalers
By Disorder
  • Chronic Obstructive Pulmonary Disease
  • Asthma
By End User
  • Home-Care Settings and Hospitals & Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Cohero Health Inc
  • Crux Product Design Ltd
  • Adherium Limited
  • Novartis AG
  • Vectura Group plc
  • Findair Sp z o o
  • Teva Pharmaceutical Industries Ltd
  • 3M
  • Amiko Digital Health Limited

    • Smart Inhalers Market News and Recent Developments

    The smart inhalers market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the smart inhalers market are listed below:

    • In February 2022, Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced the launch of HeroTracker Sense, a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device. (Source: Aptar Pharma, Press Release, February 2022)
    • In October 2021, BreatheSuite announced that it received 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, which turns existing inhalers into smart inhalers for people with asthma and COPD. (Source: BreatheSuite, Press Release, October 2021)

    Smart Inhalers Market Report Coverage and Deliverables

    The “Smart Inhalers Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Smart inhalers market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Smart inhalers market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Smart inhalers market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the smart inhalers market
    • Detailed company profiles